Developmental/Behavioral Disorders

Latest News



New research shows that almost one-third of children aged between 4 and 8 years who are diagnosed with autism spectrum disorder (ASD) also have attention-deficit/hyperactivity disorder (ADHD).

More than 90% of pediatric subspecialists who diagnose and manage attention-deficit/hyperactivity disorder (ADHD) in young children deviate from current recommendations of the American Academy of Pediatrics (AAP) and the American Academy of Child and Adolescent Psychiatry regarding treatment of pediatric ADHD.

New research reveals that children with autism spectrum disorders (ASDs) are 5 times more likely to have eating problems and subsequently nutritional deficiencies than children who do not.

Children exposed to ischemic-hypoxic events in utero are at increased risk of developing attention-deficit/hyperactivity disorder (ADHD), especially those born prematurely. The findings add to growing evidence that both prenatal and postnatal factors affect neurodevelopment.

Children with severe autism spectrum disorder (ASD) often wander away from their homes or other safe environments, placing themselves in harm's way. A new study reveals the effect wandering has on families with children who exhibit this behavior.

The US Food and Drug Administration (FDA) has approved extended-release methylphenidate hydrochloride oral suspension for the treatment of attention-deficit/hyperactivity disorder (ADHD). Efficacy was determined in a randomized, double-blind, crossover study that showed improvement for both attention and behavior metrics for up to 12 hours in children aged 6 to 12 years diagnosed with ADHD compared with placebo. The once-daily treatment will be available in January 2013.

To describe the typical longitudinal developmental trajectories of social and communication functioning and repetitive behavior in children with autism, investigators analyzed data from birth records and a database of the California Department of Developmental Services that recorded symptom severity and functioning in nearly 7,000 children aged from 2 to 14 years with autism.

Serotonin receptor inhibitors may have a small but significant effect in the treatment of restricted and repetitive behaviors in autism spectrum disorders, according to an analysis of randomized trials. But is there a publication bias?

A study of Canadian children found that the youngest children in the class are significantly more likely to be diagnosed with attention-deficit/hyperactivity disorder (ADHD) and prescribed medication than their peers in the same grade. Find out why overdiagnosis and overprescribing are a concern.